On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Hypertension has long been linked to obesity, but a new study shows that where that fat is matters. A team of researchers at University of Texas Southwestern Medical Center in Dallas, TX conclude that when that fat is in the viscera-as opposed to accumulating under the skin-there is a strong chance patients will develop hypertension.
Possibility for Personalized Psoriasis Treatment on the Horizon
Psoriasis, plaguing patients with its seemingly incurable symptoms, may have met its match. Skylit Medical, a startup in San Diego, is developing a phototherapy device to use as treatment for psoriasis as well as eczema and vitiligo.
Study Heralds Ticagrelor Use in 911 Care
AstraZeneca's beleaguered anti-platelet drug ticagrelor (Brilinta) may get a boost from a French study published online Sept. 3 in the New England Journal of Medicine. In findings also reported at the European Society of Cardiology Congress in Barcelona, Spain, Gilles Montalescot, MD, found that in a group of 1862 patients, the drug appeared to offer greater protection from stent thrombosis when administered by ambulance personnel than when given later in a cardiac cath lab.
CDC's Frieden Calls for More International Support Against Ebola Outbreak
Having seen firsthand the damage done by the Ebola virus outbreak, US Centers for Disease Control and Protection (CDC) Director Tom Frieden, MD, MPH, said that while a lot of work had been put in to help those in need, there was still a lot more work to be done.
Model Helps Predict Patient Risk for Major Type 1 Diabetes Complications
Patients diagnosed with type 1 diabetes are at higher risk for developing major health complications but up until now there had been no reliable way to determine which complications a patient might develop or how severe they might be.
Investigational Heart Failure Drug LCZ696 Gets Glowing Reviews
Novartis plans to soon file a new drug application with the US Food and Drug Administration (FDA) for its investigational heart failure drug LCZ696. A report showing the drug works better than enalapril to prevent adverse cardiac events was released at the European Society of Cardiology Congress in Barcelona, Spain Aug. 30 and published online in the New England Journal of Medicine (NEJM).
Scientists Develop ‘Electronic Nose' to Sniff Out C. Difficile Infection
Researchers at the University of Leicester have developed a highly sensitive "electronic-nose" to identify the infectious bacteria Clostridium difficile that causes diarrhea, stomach cramps, and fever in patients.
So What's Really Building up Inflammatory Bowel Disease?
Monitoring patients' own intestinal immune responses, researchers at Yale University have identified some of the bacterial culprits driving inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis.
VBLOCK Shows Success with Diabetes, Hypertension and Weight Loss
A 3-year study of a product meant to help patients dealing with a wide range of conditions including diabetes, hypertension, and weight loss showed positive results according to manufacturer EnteroMedics, Inc.
A Closer Look at Ebola and the Immune System
As national and international health agencies and other groups shift their focus during the current outbreak of the Ebola virus from treatment of those patients with the virus to preventing further large scale events, a team of researchers has reported some success in looking at how Ebola compromises an infected person's immune system.
Cost Prevents Some Rheumatoid Arthritis Patients From Needed Prescriptions
For many patients with chronic conditions such as rheumatoid arthritis, medication adherence is often one of the most challenging aspects of the treatment process, especially when the medications prescribed by their health care professional are prohibitively expensive. A study from Manchester University recently showed that many patients with rheumatoid arthritis are not taking some of their most critical medicines due to rising drug costs.
Poor Understanding of Gastroparesis Detrimental to Patients
Gastroparesis, or delayed gastric emptying, remains misunderstood despite rising prevalence, according to a news release from the International Foundation for Functional Gastrointestinal Disorders (IFFGD), a nonprofit research and education organization addressing issues surrounding gastrointestinal and motility disorders.
Researchers Find Potential Target for Ebola Treatment
The Ebola outbreak in West Africa continues to expand and around the world researchers are striving to learn more about the disease and how to stop it to ensure that any future outbreaks of the virus are not nearly as severe.